葛兰素史克赢得Zantac癌症试验，未发现药物与结直肠癌之间存在联系。 GlaxoSmithKline wins Zantac cancer trial, no link found between drug and colorectal cancer.

格拉克索史密斯克莱恩 (GSK) 公司在另一场诉讼中获胜, 控诉其已停止使用的胃灼热药物Zantac导致癌症. GlaxoSmithKline (GSK) wins another trial against claims that their discontinued heartburn drug, Zantac, caused cancer. 伊利诺伊州一名妇女的直肠癌与Zantac没有联系,Zantac含有致癌污染物NDMA。 An Illinois woman's colorectal cancer was not found to be linked with Zantac, which contains carcinogenic contaminant NDMA. 数千起针对GSK和其他制造商的诉讼在美国法院持续进行。 Thousands of lawsuits against GSK and other manufacturers persist in US courts. 美国林业发展局要求制造商在2020年将Zantac从市场上除去, The US FDA asked manufacturers to remove Zantac from the market in 2020 due to NDMA concerns.